July 24, 2016 4:13 PM ET

Pharmaceuticals

Company Overview of Celtaxsys, Inc.

Key Executives for Celtaxsys, Inc.

NameBoard RelationshipsTitleAge
Greg Duncan 22 RelationshipsChief Executive Officer, President and Director--
William P. Reddick M.H.A.No RelationshipsFounder and Chief Financial Officer--
Ralph D. Grosswald M.P.H.No RelationshipsVice President of Operations--
Sanjeev Ahuja M.D., MBA, FACPNo RelationshipsChief Medical Officer--
Eric Springman Ph.D.No RelationshipsChief Scientific Officer--

Celtaxsys, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
H. Daniel Perez M.D. 38 RelationshipsNaia Limited66
Greg Duncan 22 RelationshipsCeltaxsys, Inc.--
Michael Willingham Masters 13 RelationshipsMasters Capital Management, L.L.C.--
Stuart Elborn M.D., FRCP 30 RelationshipsProAxsis Ltd--
Richard B. Moss M.D. 48 RelationshipsProteostasis Therapeutics, Inc.--
View All Board Members

Celtaxsys, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
433.9K
Bonus
535.1K
Total Short Term Compensation
641.1K
Total Value of Options
20.5M
Compensation as of Fiscal Year
Celtaxsys, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Mallinckrodt plc Announces Resignation of Nancy S. Lurker from its Board
July 22, 2016 8:36 PM ET
Cocrystal Pharma, Inc. Announces Management Changes
July 22, 2016 12:17 PM ET
Impax Laboratories Inc. Appoints Douglas S. Boothe as President of Generics Division
July 21, 2016 8:02 PM ET
Acerus Pharmaceuticals Appoints Mr. Luc Mainville to its Board of Directors
July 21, 2016 11:00 AM ET
Perrigo Company plc Announces Executive Changes in Rx Pharmaceuticals Segment
July 21, 2016 12:55 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Celtaxsys, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.